These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30266801)

  • 1. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.
    Kim E; Zucconi BE; Wu M; Nocco SE; Meyers DJ; McGee JS; Venkatesh S; Cohen DL; Gonzalez EC; Ryu B; Cole PA; Alani RM
    Cancer Res; 2019 May; 79(10):2649-2661. PubMed ID: 30910803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MITF transcriptional activity independent of targeting p300/CBP coactivators.
    Vachtenheim J; Sestáková B; Tuhácková Z
    Pigment Cell Res; 2007 Feb; 20(1):41-51. PubMed ID: 17250547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
    Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
    Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300.
    Brown AD; Lynch K; Langelaan DN
    Sci Rep; 2023 Sep; 13(1):16094. PubMed ID: 37752231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
    Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
    Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
    Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
    Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300.
    Vannam R; Sayilgan J; Ojeda S; Karakyriakou B; Hu E; Kreuzer J; Morris R; Herrera Lopez XI; Rai S; Haas W; Lawrence M; Ott CJ
    Cell Chem Biol; 2021 Apr; 28(4):503-514.e12. PubMed ID: 33400925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.
    Martire S; Nguyen J; Sundaresan A; Banaszynski LA
    BMC Mol Cell Biol; 2020 Jul; 21(1):55. PubMed ID: 32690000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
    Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
    Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor.
    Brown AD; Vergunst KL; Branch M; Blair CM; Dupré DJ; Baillie GS; Langelaan DN
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119520. PubMed ID: 37353163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.
    Ghosh S; Taylor A; Chin M; Huang HR; Conery AR; Mertz JA; Salmeron A; Dakle PJ; Mele D; Cote A; Jayaram H; Setser JW; Poy F; Hatzivassiliou G; DeAlmeida-Nagata D; Sandy P; Hatton C; Romero FA; Chiang E; Reimer T; Crawford T; Pardo E; Watson VG; Tsui V; Cochran AG; Zawadzke L; Harmange JC; Audia JE; Bryant BM; Cummings RT; Magnuson SR; Grogan JL; Bellon SF; Albrecht BK; Sims RJ; Lora JM
    J Biol Chem; 2016 Jun; 291(25):13014-27. PubMed ID: 27056325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.
    Yokoyama S; Feige E; Poling LL; Levy C; Widlund HR; Khaled M; Kung AL; Fisher DE
    Pigment Cell Melanoma Res; 2008 Aug; 21(4):457-63. PubMed ID: 18627530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation reprograms MITF target selectivity and residence time.
    Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
    Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CBP and p300: Emerging Anticancer Agents.
    Masci D; Puxeddu M; Silvestri R; La Regina G
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
    Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
    Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.
    Wong CK; Wade-Vallance AK; Luciani DS; Brindle PK; Lynn FC; Gibson WT
    Diabetes; 2018 Mar; 67(3):412-422. PubMed ID: 29217654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.